45 results found.

Relapsing Remitting MS, Secondary Progressive MS, or Primary Prog Clinical Trial using Caprylic Triglyceride; Placebo

University of Miami - Recruiting 18 years to 59 years.
- A Randomized Double-Blind Placebo-Controlled Study of Caprylic Triglyceride for Cognitive Impairment in Subjects With Multiple Sclerosis..
Caprylic Triglyceride; Placebo

Mild Cognitive Impairment Clinical Trial using [18F]NAV4694

Navidea Biopharmaceuticals - Recruiting 55 years or older.
- Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI).
[18F]NAV4694

Amnestic Mild Cognitive Impairment, or Alzheimer's Disease Clinical Trial using Insulin (Humulinr R U-100); Placebo

Alzheimer's Disease Cooperative Study (ADCS) - Recruiting 55 years to 85 years.
- Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD).
Insulin (Humulinr R U-100); Placebo

Major Depressive Disorder Clinical Trial using Etomidate; Propofol; Bilateral temporal MECT; The right temporal MECT; Bilateral frontal MECT

Shanghai Mental Health Center - Recruiting 18 years or older.
- The Efficacy And Cognitive Impairment Of Modified Electroconvulsive Therapy: A Randomized Clinical Trial And Its Standard Technology Promotion Research.
Etomidate; Propofol; Bilateral temporal MECT; The right temporal MECT; Bilateral frontal MECT

Hunter Syndrome Clinical Trial using idursulfase-IT; No IT treatment

Shire Human Genetic Therapies, Inc. - Recruiting N/A to 18 years.
- A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elapraser in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment.
idursulfase-IT; No IT treatment

Amnestic Mild Cognitive Impairment, Alzheimer's Disease, or Prodr Clinical Trial using MK-8931; Placebo

Merck Sharp & Dohme Corp. - Recruiting 50 years to 85 years.
- A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 (SCH 900931) in Subjects With Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal AD).
MK-8931; Placebo

Mild Cognitive Impairment, or Mild to Moderate Cognitive Impairme Clinical Trial using spectral-domain optical coherence tomography (SD-OCT)

Duke University - Recruiting 55 years or older.
- Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease.
spectral-domain optical coherence tomography (SD-OCT)

Mild Cognitive Impairment (MCI) Clinical Trial using Behavioral Activation (BA); Supportive Therapy (ST)

Thomas Jefferson University - Recruiting 65 years or older.
- Preventing Cognitive Decline in African Americans With Mild Cognitive Impairment.
Behavioral Activation (BA); Supportive Therapy (ST)

Mild Cognitive Impairment Due to Alzheimer's Disease Clinical Trial using Pioglitazone; Pioglitazone placebo

Takeda - Recruiting 65 years to 83 years.
- A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Simultaneously Qualify a Biomarker Algorithm for Prognosis of Risk of Developing Mild Cognitive Impairment Due to Alzheimer's Disease (MCI Due to AD) and to Test the Safety and Efficacy of Pioglitazone (AD-4833 0.8 SR mg QD) to Delay the Onset of MCI Due to AD in Cognitively Normal Subjects.
Pioglitazone; Pioglitazone placebo

Complications of Prematurity Clinical Trial using Cognitive evaluation (Wechsler IV tests)

Maternite Regionale Universitaire - Recruiting 8 years to 11 years.
- Prematurity Related Risks of Cognitive Impairment at School Age With Regards to Social, Family and Care Environment.
Cognitive evaluation (Wechsler IV tests)

Mild Cognitive Impairment Clinical Trial using External Counterpulsation (EECP)

University of Kansas - Recruiting 18 years to 85 years.
- Enhanced External Counterpulsation and Its Effects on Vascular Hemodynamics in Cognitively Impaired Patients.
External Counterpulsation (EECP)

Risk Behavior, or Mental Health Impairment Clinical Trial using Trauma-Focused Cognitive Behavioral Therapy; Psychosocial Counseling

Johns Hopkins Bloomberg School of Public Health - Recruiting 13 years to 17 years.
- Randomized Controlled Trial of Ways to Improve OVC HIV Prevention and Well-being.
Trauma-Focused Cognitive Behavioral Therapy; Psychosocial Counseling

Parkinson's Disease, or Mild Cognitive Impairment Clinical Trial using Memory and Problem-Solving Intervention; Supportive Therapy

Virginia Commonwealth University - Recruiting 18 years or older.
- A Randomized Controlled Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease.
Memory and Problem-Solving Intervention; Supportive Therapy

Mild Cognitive Impairment Clinical Trial

University of California, Los Angeles - Recruiting 60 years to 89 years.
- Physical Activity Levels and Hippocampal Sub-region Structure in MCI.

Vascular Mild Cognitive Impairment Clinical Trial using Attention Process Training-II

Azienda Ospedaliero-Universitaria Careggi - Recruiting 18 years or older.
- The Rehabilitation of Attention in Patients With Mild Cognitive Impairment and Brain Subcortical Vascular Changes Using the Attention Process Training-II.
Attention Process Training-II

Alzheimer Disease, Mild Cognitive Impairment, or Delirium, Dement Clinical Trial using Donepezil

New York State Psychiatric Institute - Recruiting 55 years to 95 years.
- Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly.
Donepezil

Mild Cognitive Impairment Clinical Trial using Donepezil; Atropine

New York State Psychiatric Institute - Recruiting 55 years to 95 years.
- Olfactory Deficits in Mild Cognitive Impairment as a Predictor of Improved Cognition on Donepezil.
Donepezil; Atropine

End Stage Renal Disease Clinical Trial using Kidney Transplant

University of Kansas - Recruiting 30 years to 70 years.
- Cognitive Impairment and Imaging Correlates in End Stage Renal Disease.
Kidney Transplant

Mild Cognitive Impairment Clinical Trial using Atkins low carbohydrate diet; Healthy high carbohydrate diet

University of Cincinnati - Recruiting 60 years or older.
- Energy Metabolism and Cognitive Aging.
Atkins low carbohydrate diet; Healthy high carbohydrate diet

Alzheimer's Disease Clinical Trial using florbetapir F 18; 18F-AV-1451

Avid Radiopharmaceuticals - Recruiting 20 years or older.
- An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease.
florbetapir F 18; 18F-AV-1451

Mild Cognitive Impairment Clinical Trial using Medium Chain Triglyceride Oil; Placebo Oil

Pennington Biomedical Research Center - Recruiting 50 years or older.
- Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment.
Medium Chain Triglyceride Oil; Placebo Oil

Mild Cognitive Impairment Clinical Trial using Kundalini yoga and meditation; Memory Training

University of California, Los Angeles - Recruiting 55 years to 90 years.
- Memory Training Versus Yogic Meditation Training in Older Adults With Mild Cognitive Impairment.
Kundalini yoga and meditation; Memory Training

Diabetic Neuropathy, or Cognitive Impairment Clinical Trial using Tocotrienol; Placebo

University of Science Malaysia - Recruiting 20 years or older.
- A Clinical Study on the Neuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus.
Tocotrienol; Placebo

Mild Cognitive Impairment, So Stated Clinical Trial using Stimulation; SHAM

Charite University, Berlin, Germany - Recruiting 50 years to 80 years.
- Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Nocturnal Slow Wave Sleep in Patients With Mild Cognitive Impairments(MCI).
Stimulation; SHAM

Mild Cognitive Impairment, Alzheimer's Disease, or Traumatic Brai Clinical Trial using explicit memory training; implicit memory training

Department of Veterans Affairs - Recruiting 18 years to 88 years.
- Behavioral and Neuroimaging Changes After Cognitive Rehab in TBI and MCI.
explicit memory training; implicit memory training

Chronic Fatigue Syndrome, Muscular Diseases, Cognitive Impairment Clinical Trial using Acupuncture.

Hospital Vall d'Hebron - Recruiting 18 years to 70 years.
- Clinical Trial, Randomized, Controlled, Parallel, to Evaluate the Effectiveness of Acupuncture as a Treatment in Patients Diagnosed With Chronic Fatigue Syndrome..
Acupuncture.

Mild Cognitive Impairment Clinical Trial using Transcranial direct current stimulation

The University of New South Wales - Recruiting 60 years to 85 years.
- .
Transcranial direct current stimulation

Mild Cognitive Impairment Clinical Trial using Simvastatin; Placebo

Charite University, Berlin, Germany - Recruiting 55 years to 90 years.
- Randomized Controlled Trial of Simvastatin in Amnestic MCI Patients.
Simvastatin; Placebo

Mild Cognitive Impairment (MCI), or Alzheimer's Disease Clinical Trial

Alzheimer's Disease Cooperative Study (ADCS) - Recruiting 55 years to 90 years.
- Alzheimer's Disease Neuroimaging Initiative 2.

Cognitive Impairment Clinical Trial using Dual task gait training; Aerobic exercise class

Parkwood Hospital, London, Ontario - Recruiting 60 years to 85 years.
- Study of Community Based and Institutional Dual Task and Aerobic Exercise Intervention on Cognition and Mobility in Older Adults With Cognitive Impairment-no Dementia.
Dual task gait training; Aerobic exercise class

Mild Cognitive Impairment Clinical Trial using Omega-3 fatty acid supplementation

Clinica Universidad de Navarra, Universidad de Navarra - Recruiting 75 years or older.
- Field Trial With Omega-3 Fatty Acid Supplementation for the Prevention of Cognitive Decline in a Very Elderly Population.
Omega-3 fatty acid supplementation

Memory Disorders, Alzheimer Disease, Dementia, Cognitive Impairme Clinical Trial using COGNISIONT System

Neuronetrix, Inc. - Recruiting 60 years to 90 years.
- Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISIONT) as a Useful Cognitive Biomarker for Alzheimer's Disease..
COGNISIONT System

Parkinson's Disease, or Cognitive Impairment Clinical Trial using Atomoxetine; Placebo

Medical University of South Carolina - Recruiting 35 years to 75 years.
- Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog).
Atomoxetine; Placebo

Parkinson Disease, or Cognitive Impairment Clinical Trial

University of Washington - Recruiting 18 years or older.
- Pacific Northwest Udall Center (PANUC) Clinical Core.

Diabetes Mellitus, Type 2, Metabolic Syndrome X, or Mild Cognitiv Clinical Trial

Maastricht University Medical Center - Recruiting 40 years to 75 years.
- Functional MRI Biomarkers of Cognitive Decrements in Diabetes.

Falls, Gait, Balance, or Mild Cognitive Impairment (MCI) Clinical Trial using Donepezil

Lawson Health Research Institute - Recruiting 65 years or older.
- Can Cognitive Enhancers Reduce the Risk of Falls in Older People With Mild Cognitive Impairment? A Randomized Controled Trial.
Donepezil

Alzheimers Disease, or Mild Cognitive Impairment Clinical Trial

Roskilde County Hospital - Recruiting 50 years to 90 years.
- Quantitative Electroencephalography, Cerebrospinal Fluid Biomarkers, Linear CT Analyses and Timed Up and GO Dual Task as Diagnostic Tools in Dementia and Their Ability to Predict Disease Progression..

Femoral Fracture, Blood Pressure, or Cognitive Impairment Clinical Trial

Hospital de Sabadell - Recruiting 70 years or older.
- Observational Study of Cerebral Oxygenation and Spinal Anaesthesia in Elderly Patients With Hip Fracture.

Mild Cognitive Impairment Clinical Trial using Grape Powder; Placebo Powder

University of California, Los Angeles - Recruiting 65 years or older.
- Examining the Impact of Grape Consumption on Brain Metabolism and Cognitive Function in Patients With Mild Cognitive Impairment.
Grape Powder; Placebo Powder

Mild Cognitive Impairment, or Cognitive Disorders Clinical Trial using 5-month aerobic exercise intervention

Wake Forest School of Medicine - Recruiting 60 years or older.
- Community-based, Buddy-supported Exercise in Patients With MCI: a Pilot Trial.
5-month aerobic exercise intervention

Alzheimer's Disease, Mild Cognitive Impairment, or Age-Related Me Clinical Trial

University of Arizona - Recruiting 50 years or older.
- Arizona Alzheimer's Disease Core Center.

Substance Abuse, Substance Dependence, or Cognitive Impairment Clinical Trial using Cognitive Training + Work Therapy; Work Therapy

Yale University - Recruiting 18 years or older.
- Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment.
Cognitive Training + Work Therapy; Work Therapy

Alzheimer's Disease, Dementia, or Neurodegenerative Disorders Clinical Trial using Blood sampling, skin biopsy

Institut National de la Sant‚ Et de la Recherche M‚dicale, France - Recruiting 18 years to 90 years.
- Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment.
Blood sampling, skin biopsy

Depression Clinical Trial using Problem-solving therapy; Nutritional education program

National Institute of Mental Health (NIMH) - Recruiting 18 years or older.
- Prevention of Psychiatric Morbidity in AD Caregivers.
Problem-solving therapy; Nutritional education program

Mild Cognitive Impairment (MCI) Clinical Trial using melatonin; placebo like melatonin tablets

Assaf-Harofeh Medical Center - Recruiting 55 years to 90 years.
- The Effect of Melatonin on Memory and Other Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment (MCI): A Placebo- Controlled Study..
melatonin; placebo like melatonin tablets